Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,000
Closed -$1K 4037
2023
Q2
$1K Hold
4,000
﹤0.01% 3309
2023
Q1
$1K Buy
+4,000
New +$77.7K ﹤0.01% 3450
2020
Q2
Sell
-4,000
Closed -$1K 4609
2020
Q1
$1K Buy
+4,000
New +$94.8K ﹤0.01% 3717
2018
Q4
Sell
-5,000
Closed -$3K 4229
2018
Q3
$3K Buy
+5,000
New +$113K ﹤0.01% 3322
2018
Q1
Sell
-3,100
Closed -$44K 4808
2017
Q4
$44K Sell
3,100
-51,500
-94% -$1.52M ﹤0.01% 1963
2017
Q3
$550K Buy
54,600
+43,400
+388% +$827K 0.02% 613
2017
Q2
$20K Sell
11,200
-8,900
-44% -$152K ﹤0.01% 3410
2017
Q1
$35K Buy
20,100
+200
+1% +$3.08K ﹤0.01% 2742
2016
Q4
$6K Sell
19,900
-9,200
-32% -$126K ﹤0.01% 4752
2016
Q3
$24K Buy
+29,100
New +$364K ﹤0.01% 3230
2016
Q2
Sell
-17,900
Closed -$6K 6935
2016
Q1
$6K Sell
17,900
-100
-0.6% -$1.31K ﹤0.01% 4647
2015
Q4
$34K Buy
+18,000
New +$317K ﹤0.01% 2863

Other funds holding INSM

Cutler Group's INSM Position: Q4 2023 in Review

Cutler Group sold out of Insmed (INSM) in Q4 2023, closing a stake of 1,600 shares — an estimated $40K sold.

Cutler Group first reported a position in INSM in Q4 2015 and held it in 15 quarters. The position peaked at $144K in Q3 2017. 271 funds tracked by Wall St. Rank hold INSM as of Q4 2023.

  • Cutler Group reported no remaining Insmed position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 1,600 Insmed shares in Q4 2023, an estimated $40K.
  • Cutler Group first reported a position in Insmed in Q4 2015 and held it in 15 quarters.
  • Cutler Group's Insmed position peaked at $144K in Q3 2017.
  • 271 funds tracked by Wall St. Rank held Insmed as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.